Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Hologic
(NASDAQ:HOLX)
Intraday
$75.71
0
[0.00%]
After-Hours
$75.71
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$75.71
0
[0.00%]
At close: Apr 25
$75.71
0
[0.00%]
PreMarket: 4:00PM EDT
Get Report
Watch
Q2 2024 Earnings in 6 days from now on Thu May 2nd, after the market close
Conference call scheduled in 6 days at 16:30 PM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Hologic Stock (NASDAQ:HOLX)
Hologic Stock (NASDAQ: HOLX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 10, 2024
Needham Reiterates Buy on Hologic, Maintains $90 Price Target
Benzinga Newsdesk
-
Apr 10, 2024, 5:21AM
Thursday, April 04, 2024
Evercore ISI Group Maintains In-Line on Hologic, Raises Price Target to $78
Benzinga Newsdesk
-
Apr 4, 2024, 12:44PM
Wednesday, April 03, 2024
The Analyst Landscape: 4 Takes On Hologic
Benzinga Insights
-
Apr 3, 2024, 11:00AM
CORRECTION: Citigroup Upgrades Hologic to Buy, Raises Price Target to $95 - Rating change updated
Benzinga Newsdesk
-
Apr 3, 2024, 10:49AM
Citigroup Maintains Neutral on Hologic, Raises Price Target to $95
Benzinga Newsdesk
-
Apr 3, 2024, 10:28AM
Tuesday, March 05, 2024
Hologic Published Results Suggest Proportion Of Early-Stage HR+ Breast Cancer Survivors May Be Over- Or Undertreated Without Breast Cancer Index Genomic Testing
Benzinga Newsdesk
-
Mar 5, 2024, 8:12AM
Wednesday, February 21, 2024
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
Vandana Singh
-
Feb 21, 2024, 12:24PM
Friday, February 02, 2024
UBS Maintains Neutral on Hologic, Raises Price Target to $79
Benzinga Newsdesk
-
Feb 2, 2024, 1:47PM
Raymond James Maintains Outperform on Hologic, Raises Price Target to $88
Benzinga Newsdesk
-
Feb 2, 2024, 9:10AM
Amazon To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
-
Feb 2, 2024, 7:33AM
Analyst Ratings For Hologic
Benzinga Insights
-
Feb 2, 2024, 7:00AM
Needham Maintains Buy on Hologic, Raises Price Target to $90
Benzinga Newsdesk
-
Feb 2, 2024, 6:01AM
Thursday, February 01, 2024
Hologic Says New Genius Digital Diagnostics System With The Genius Cervical AI Algorithm Received Clearance From FDA
Benzinga Newsdesk
-
Feb 1, 2024, 5:41PM
Hologic Expects Q2 Revenue Of $990M-$1.01B (Est $998.09M), Adj EPS Of $0.95-$1.00 (Est $0.98)
Benzinga Newsdesk
-
Feb 1, 2024, 5:24PM
Hologic Reports Better-Than-Expected Q1 Results
Erica Kollmann
-
Feb 1, 2024, 4:52PM
Hologic Raises FY24 Adj EPS Forecast From $3.90-$4.10 To $3.97-$4.12 (Est $4.00), Revenue From $3.92B-$4.02B To $3.99B-$4.065B (Est $3.99B)
Benzinga Newsdesk
-
Feb 1, 2024, 4:21PM
Recap: Hologic Q1 Earnings
Benzinga Insights
-
Feb 1, 2024, 4:15PM
Hologic Q1 Adj EPS $0.98 Beats $0.95 Estimate, Sales $1.01B Beat $986.12M Estimate
Benzinga Newsdesk
-
Feb 1, 2024, 4:02PM
Earnings Scheduled For February 1, 2024
Benzinga Insights
-
Feb 1, 2024, 5:03AM
Wednesday, January 31, 2024
Earnings Outlook For Hologic
Benzinga Insights
-
Jan 31, 2024, 4:01PM
Tuesday, January 09, 2024
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
-
Jan 9, 2024, 6:36AM
Sunday, January 07, 2024
Hologic Announces Preliminary Revenue Results For Q1 2024; Sees Q1 Revenue Of $1.013B Vs $978.96M Est.
Benzinga Newsdesk
-
Jan 7, 2024, 5:18PM
Thursday, November 30, 2023
KKR, Hologic and Ajax Health Create New Platform Named Maverix Medical to Accelerate Medical Device Innovation, Platform Will Focus On Technologies To Detect Lung Cancer
Benzinga Newsdesk
-
Nov 30, 2023, 6:08AM
Thursday, November 16, 2023
UBS Maintains Neutral on Hologic, Lowers Price Target to $78
Benzinga Newsdesk
-
Nov 16, 2023, 1:20PM
Monday, November 13, 2023
Where Hologic Stands With Analysts
Benzinga Insights
-
Nov 13, 2023, 3:00PM
Morgan Stanley Maintains Equal-Weight on Hologic, Lowers Price Target to $82
Benzinga Newsdesk
-
Nov 13, 2023, 9:07AM
Friday, November 10, 2023
RBC Capital Maintains Sector Perform on Hologic, Lowers Price Target to $72
Benzinga Newsdesk
-
Nov 10, 2023, 2:10PM
Tech Stocks Soar, Microsoft Reaches Record High As AI Rally Resumes: What's Driving Markets Friday?
Shanthi Rexaline
-
Nov 10, 2023, 1:57PM
Hologic shares are trading higher after the company reported better-than-expected Q4 financial results and issued guidance.
Benzinga Newsdesk
-
Nov 10, 2023, 12:19PM
Big Stocks Moving Higher On Friday: Synaptics Reports Q1 Beat; Joins Lyft, Hologic, Blink Charging
Lisa Levin
-
Nov 10, 2023, 11:51AM
Thursday, November 09, 2023
Hologic Intends To Enter Into An Accelerated Share Repurchase Agreement For $500M Of The Company's Common Stock
Benzinga Newsdesk
-
Nov 9, 2023, 4:16PM
Hologic Sees Q1 EPS $0.92-$0.97 Vs $0.95 Est.; Revenue $960M-$985M Vs $1.02B Est.; FY24 EPS $3.90-$4.10 Vs $3.91 Est.; Revenue $3.92B-$4.02B Vs $4.02B Est.
Benzinga Newsdesk
-
Nov 9, 2023, 4:06PM
Hologic Q4 Adj $0.89 Beats $0.84 Estimate, Sales $945.30M Beat $940.04M Estimate
Benzinga Newsdesk
-
Nov 9, 2023, 4:04PM
Traders Hold Breath For Powell's Remarks, Bitcoin's Wild Ride Unleashed: What's Driving Markets Thursday?
Shanthi Rexaline
-
Nov 9, 2023, 1:22PM
Earnings Scheduled For November 9, 2023
Benzinga Insights
-
Nov 9, 2023, 6:52AM
Friday, November 03, 2023
Shares of healthcare equipment and healthcare provider stocks are trading higher amid overall market strength. Strength may also be attributed to Cardinal Health after the company reported better-than-expected Q1 financial results.
Benzinga Newsdesk
-
Nov 3, 2023, 3:33PM
Thursday, October 26, 2023
Needham Maintains Buy on Hologic, Lowers Price Target to $83
Benzinga Newsdesk
-
Oct 26, 2023, 5:40AM
Wednesday, October 18, 2023
Raymond James Maintains Outperform on Hologic, Lowers Price Target to $85
Benzinga Newsdesk
-
Oct 18, 2023, 7:52AM
Tuesday, October 10, 2023
Hologic Announces Innovative Collaboration With AAGL And Inovus Medical To Optimize OB-GYN Training For Minimally Invasive Surgeries
Benzinga Newsdesk
-
Oct 10, 2023, 8:44AM
Thursday, October 05, 2023
The Latest Analyst Ratings for Hologic
Benzinga Insights
-
Oct 5, 2023, 4:00PM
RBC Capital Maintains Sector Perform on Hologic, Lowers Price Target to $77
Benzinga Newsdesk
-
Oct 5, 2023, 12:04PM
Thursday, September 21, 2023
Hologic, Bayer Announce International Partnership For Contrast-Enhanced Mammography Package To Breast Imaging Facilities
Benzinga Newsdesk
-
Sep 21, 2023, 8:35AM
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
Vandana Singh
-
Sep 21, 2023, 7:16AM
Friday, September 15, 2023
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Sep 15, 2023, 1:35PM
Tuesday, August 01, 2023
Hologic Stock Falls After Q3 Revenue Dip, But It Lifts Revenue and Profit Outlook
Vandana Singh
-
Aug 1, 2023, 3:49PM
Analyst Expectations for Hologic's Future
Benzinga Insights
-
Aug 1, 2023, 3:00PM
Morgan Stanley Reiterates Equal-Weight on Hologic, Maintains $86 Price Target
Benzinga Newsdesk
-
Aug 1, 2023, 11:25AM
Citigroup Maintains Neutral on Hologic, Lowers Price Target to $85
Benzinga Newsdesk
-
Aug 1, 2023, 10:15AM
RBC Capital Maintains Sector Perform on Hologic, Lowers Price Target to $85
Benzinga Newsdesk
-
Aug 1, 2023, 9:11AM
B of A Securities Maintains Neutral on Hologic, Lowers Price Target to $86
Benzinga Newsdesk
-
Aug 1, 2023, 8:38AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch